Biomarkers for predicting response to aspirin therapy in aspirin-exacerbated respiratory disease.
Katarzyna E TyrakKinga PajdzikBogdan JakiełaIzabela Kupryś-LipińskaAdam ĆmielRadosław KacorzykGabriela TrądPiotr KunaMarek SanakLucyna MastalerzPublished in: Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology (2021)
Female sex, high blood eosinophil count, low sputum neutrophil percentage, severe nasal symptoms, high HPGD expression and low PRG2 expression may predict a positive response to long-term high-dose aspirin therapy in patients with AERD.
Keyphrases
- low dose
- high dose
- poor prognosis
- cardiovascular events
- antiplatelet therapy
- mycobacterium tuberculosis
- cystic fibrosis
- pulmonary tuberculosis
- long non coding rna
- cardiovascular disease
- stem cell transplantation
- anti inflammatory drugs
- acute coronary syndrome
- type diabetes
- bone marrow
- atrial fibrillation
- chronic rhinosinusitis
- peripheral blood